Seroprevalence of antibodies to influenza A/H1N1/2009 among transmission risk groups after the second wave in Mexico, by a virus-free ELISA method

International Journal of Infectious Diseases

Volumn 15, Issue 11, 2011, Pages

  Elizondo Montemayor, Leticia ^a   Alvarez, Mario M ^a   Hernández Torre, Martín ^a   Ugalde Casas, Patricia A ^a   Lam Franco, Lorena ^a   Bustamante Careaga, Humberto ^a   Castilleja Leal, Fernando ^a   Contreras Castillo, Julio ^a   Moreno Sánchez, Héctor ^a   Tamargo Barrera, Daniela ^a   López Pacheco, Felipe ^a   Freiden, Pamela J ^b   Schultz Cherry, Stacey ^b  

^a SCHOOL OF ENGINEERING AND SCIENCES   (Mexico)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

A H1N1 2009; Antibodies; Pandemic influenza; Risk group; Seroprevalence

Indexed keywords

VIRUS ANTIBODY; VIRUS ANTIGEN; VIRUS HEMAGGLUTININ;

2009 H1N1 INFLUENZA; ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; COLLEGE STUDENT; DISEASE TRANSMISSION; ELEMENTARY STUDENT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GROUPS BY AGE; HEALTH CARE PERSONNEL; HIGH RISK POPULATION; HIGH SCHOOL STUDENT; HUMAN; INFLUENZA A (H1N1); INFLUENZA VIRUS A H1N1; MAJOR CLINICAL STUDY; MALE; MEXICO; MIDDLE SCHOOL STUDENT; NURSING HOME PATIENT; PRESCHOOL CHILD; RECEPTOR BINDING; SCHOOL CHILD; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SEROPREVALENCE; TEACHER;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CHILD; CROSS-SECTIONAL STUDIES; DISEASE OUTBREAKS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FACULTY; FEMALE; HEALTH PERSONNEL; HUMANS; INCIDENCE; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MEXICO; MIDDLE AGED; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SEROEPIDEMIOLOGIC STUDIES; STUDENTS; YOUNG ADULT;

EID: 80054963192     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2011.07.002     Document Type: Article

References (41)

1. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009, 360:2605-2615. Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team.
2. World Health Organization. Influenza-like illness in the United States and Mexico, 2009. Geneva: WHO; 2009. Available at: (accessed March 2010). http://www.who.int/csr/don/2009_04_24/es/index.html.
3. World Health Organization. Pandemic H1N1 2009-update 108. Geneva: WHO; 2010. Available at: (accessed July 2010). http://www.who.int/csr/don/2010_07_09/en/index.html.
4. Secretaría de Salud de México. Situación actual de la epidemia: Julio 5, 2010. Mexico: Secretaría de Salud; 2010. Available at: (accessed July 2010). http://portal.salud.gob.mx/sites/salud/descargas/pdf/influenza/situacion_actual_epidemia_050710.pdf.
5. Ross T., Zimmer S., Burke D., Crevar C., Carter D., Stark J., et al. Seroprevalence following the second wave of pandemic 2009 H1N1 influenza. PLoS Curr 2010, 2. RRN1148.
6. Miller E., Hoschler K., Hardelid P., Stanford E., Andrews N., Zambon M. Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study. Lancet 2010, 375:1100-1108.
7. Reed C., Angulo F.J., Swerdlow D.L., Lipsitch M., Meltzer M.I., Jernigan D., et al. Estimates of the prevalence of pandemic (H1N1) 2009, United States, April-July 2009. Emerg Infect Dis 2009, 15:2004-2007.
8. Rizzo C., Rota M.C., Bella A., Alfonsi V., Declich S., Caporali M.G., et al. Cross-reactive antibody responses to the 2009 A/H1N1v influenza virus in the Italian population in the pre-pandemic period. Vaccine 2010, 28:3558-3562.
9. Chen H., Wang Y., Liu W., Zhang J., Dong B., Fan X., et al. Serologic survey of pandemic (H1N1) 2009 virus, Guangxi Province, China. Emerg Infect Dis 2009, 15:1849-1850.
10. Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR Morb Mortal Wkly Rep 2009, 58:521-524. Centers for Disease Control and Prevention.
11. Colizza V., Vespignani A., Perra N., Poletto C., Gonçalves B., Hu H., et al. Estimate of novel influenza A/H1N1 cases in Mexico at the early stage of the pandemic with a spatially structured epidemic model. PLoS Curr Influenza 2009, 1. RRN1129.
12. Cruz-Pacheco G., Duran L., Esteva L., Minzoni A., Lopez-Cervantes M., Panayotaros P., et al. Modelling of the influenza A(H1N1)v outbreak in Mexico City, April-May 2009, with control sanitary measures. Euro Surveill 2009, 14. pii: 19254.
13. Lipsitch M., Hayden F.G., Cowling B.J., Leung G.M. How to maintain surveillance for novel influenza A H1N1 when there are too many cases to count. Lancet 2009, 374:1209-1211.
14. Zimmer S.M., Crevar C.J., Carter D.M., Stark H., Giles B.M., Zimmerman R.K., et al. Seroprevalence following the second wave of pandemic 2009 H1N1 influenza in Pittsburgh, PA, USA. PLoS One 2010, 5:e11601.
15. Adamson W.E., Maddi S., Robertson C., McDonagh S., Molyneaux P.J., Templeton K.E., et al. 2009 pandemic influenza A(H1N1) virus in Scotland: geographically variable immunity in spring 2010, following the winter outbreak. Euro Surveill 2010, 15. pii: 19590.
16. Chen M.I., Lee V.J., Lim W.Y., Barr I.G., Lin R.T., Koh G.C., et al. 2009 Influenza A(H1N1) seroconversion rates and risk factors among distinct adult cohorts in Singapore. JAMA 2010, 303:1383-1391.
17. Chan Y.J., Lee C.L., Hwang S.J., Fung C.P., Wang F.D., Yen D.H.T., et al. Seroprevalence of antibodies to pandemic (H1N1) 2009 influenza virus among hospital staff in a medical center in Taiwan. J Chin Med Assoc 2010, 73:62-66.
18. Hancock K., Veguilla V., Lu X., Zhong W., Butler E.N., Sun H., et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 2009, 361:1945-1952.
19. Secretaría de Educación en el Estado de Nuevo León. Alumnos por género inicio de cursos 2008-2009. Mexico: Secretaría de Educación en el Estado de Nuevo León; Available at: (accessed July 2008). http://www.nl.gob.mx/pics/pages/sec_ed_alimnos0809_base/MONTERREY.pdf.
20. Secretaría de Educación en el Estado de Nuevo León. Docentes por género inicio de cursos 2008-2009. Mexico: Secretaría de Educación en el Estado de Nuevo León; Available at: (accessed July 2010). http://www.nl.gob.mx/%3FP=estadisticas_edu_docentes0809.
21. Sistema Nacional de Información en Salud. Población total, hombres y mujeres a mitad de cada año por edad quinquenal según municipio. Mexico:; Available at: (accessed October 2008). http://www.sinais.salud.gob.mx/demograficos/poblacion.html.
22. Alvarez M.M., López-Pacheco F., Aguilar-Yañez J.M., Portillo-Lara R., Mendoza-Ochoa G.I., Freiden P., et al. Specific recognition of influenza A/H1N1/2009 antibodies in human serum: a simple virus-free ELISA method. PLoS One 2009, 5:e10176. Sistema Nacional de Información en Salud.
23. Aguilar-Yáñez J.M., Portillo-Lara R., Mendoza-Ochoa G.I., García-Echauri S.A., López-Pacheco F., Bulnes-Abundis D., et al. An influenza A/H1N1/2009 hemagglutinin vaccine produced in Escherichia coli. PLoS One 2010, 5:e11694.
24. DuBois R.M., Aguilar-Yañez J.M., Mendoza-Ochoa G.I., Oropeza-Almazán Y., Schultz-Cherry S., Alvarez M.M., et al. The receptor-binding domain of influenza virus hemagglutinin produced in Escherichia coli folds into its native, immunogenic structure. J Virol 2011, 85:865-872.
25. Secretaría de Salud de México. Situación actual de la epidemia: Mayo 12, 2009. Mexico: Secretaría de Salud; 2009. Available at: (accessed July 2010). http://portal.salud.gob.mx/sites/salud/descargas/pdf/influenza/situacion_actual_epidemia_120509.pdf.
26. López-Pacheco F, Aguilar-Yañez JM, Portillo-Lara R, Mendoza-Ochoa GI, García-Echauri S, Oropeza-Almazan Y, et al. Specific recognition of influenza A/H1N1/2009 antibodies in human serum: a simple virus-free ELISA method. Conference Proceedings. Options for the Control of Influenza VII, Hong Kong SAR, China, September 3-7, 2010.
27. López-Pacheco F., Mendoza-Ochoa G., Freiden P., Oropeza-Almazán Y., Shultz-Cherry S., Zertuche-Guerra M.I., et al. Virus-free ELISA method for the determination of influenza A/H1N1/2009 antibodies in human serum. Influenza Other Respi Viruses 2011, 5(Suppl 1):135-138.
28. Sullivan S.J., Jacobson R.M., Dowdle W.R., Poland G.A. 2009 H1N1 influenza. Mayo Clin Proc 2010, 85:64-76.
29. Garske T., Legrand J., Donnelly C.A., Ward H., Cauchemez S., Fraser C., et al. Assessing the severity of the novel influenza A/H1N1 pandemic. BMJ 2009, 339:b2840.
30. Perez-Padilla R., Rosa-Zamboni D., Ponce-de-Leon S., Hernandez M., Quiñones-Falconi F., Bautista E., et al. Pneumonia and respiratory failure from swine-origin influenza A(H1N1) in Mexico. N Engl J Med 2010, 361:680-689.
31. Echevarría-Zuno S., Mejía-Aranguré J.M., Mar-Obeso A.J., Grajales-Muñiz C., Robles-Pérez E., González-León M., et al. Infection and death from influenza A H1N1 virus in Mexico: a retrospective analysis. Lancet 2009, 374:2072-2079.
32. Ikonen N., Strengell M., Kinnunen L., Osterlund P., Pirhonen J., Broman M., et al. High frequency of cross-reacting antibodies against 2009 pandemic influenza A(H1N1) virus among the elderly in Finland. Euro Surveill 2010, 15. pii: 19478.
33. Mossong J., Hens N., Jit M., Beutels P., Auranen K., Mikolajczyk R., et al. Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Med 2008, 5:e74.
34. Peiris J.M., Poon L.L., Guan Y. Emergence of a novel swine-origin influenza A virus (S-OIV) H1N1 virus in humans. J Clin Virol 2009, 45:169-173.
35. Zhu F.C., Wang H., Fang H.H., Yang J.G., Lin X.J., Liang X.F., et al. A novel influenza A (H1N1) vaccine in various age groups. N Engl J Med 2009, 361:2414-2423.
36. Health Protection Agency. Pandemic (H1N1) 2009 influenza: surveillance methodology, Nov 25, 2009. London: HPA; 2009. Available at: (accessed March 2010). http://www.hpa.org.uk/web/HPAweb%26Page%26HPAwebAutoListName/Page/1259151885940.
37. Turbelin C., Pelat C., Boelle P.Y., Lévy-Bruhl D., Carrat F., Blanchon T., et al. Early estimates of 2009 pandemic influenza A(H1N1) virus activity in general practice in France: incidence of influenza-like illness and age distribution of reported cases. Euro Surveill 2009, 14. pii: 19341.
38. Centers for Disease Control and Prevention. CDC estimates of 2009 H1N1 influenza cases, hospitalizations and deaths in the United States, April-November 14, 2009. Atlanta, GA: CDC; 2009. Available at: (accessed March 2010). http://www.cdc.gov/h1n1flu/estimates_2009_h1n1.htm.
39. Secretaría de Salud del Estado de Nuevo León. Influenza humana (AH1N1): casos de influenza AH1N1 en Nuevo León hasta el 29 de junio de 2010. Mexico: Secretaría de Educación en el Estado de Nuevo León; 2010. Available at: (accessed July 2010). http://www.nl.gob.mx/%3FP=influenza.
40. Fraser C., Donnelly C.A., Cauchemez S., Hanage W.P., Van Kerkhove M.D., Hollingsworth T.D., et al. Pandemic potential of a strain of influenza A (H1N1): early findings. Science 2009, 324:1557-1561.
41. Reed C., Katz J.M. Serological surveys for 2009 pandemic influenza A H1N1. Lancet 2010, 375:1062-1063.